Segment disclosures

Company overview

Bicycle Therapeutics plc

Each reported dimension combination stays separate. Revenue and operating income are shown as reported, with their dates and sources.

Revenue · Reported segment facts

1 dimension combinations 19 retained observations 13 reported periods

Counts describe retained dimensioned rows only. Periods and members can change across reports, and this view does not infer missing values or expected segment totals.

Single Reportable Segment

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=bcyc:SingleReportableSegmentMember
PeriodValueUnitFiledEvidence
2026-07-01 – 2026-09-3034057000 USD2026-10-29 · 11:12:53.000ZOpen filing evidence
2026-01-01 – 2026-09-3035573000 USD2026-10-29 · 11:12:53.000ZOpen filing evidence
2026-04-01 – 2026-06-30629000 USD20260730Open filing evidence
2026-01-01 – 2026-06-301516000 USD20260730Open filing evidence
2026-01-01 – 2026-03-31887000 USD20260430Open filing evidence
2025-01-01 – 2025-12-3172586000 USD20260317Open filing evidence
2025-07-01 – 2025-09-3011734000 USD2026-10-29 · 11:12:53.000ZOpen filing evidence
2025-01-01 – 2025-09-3024631000 USD2026-10-29 · 11:12:53.000ZOpen filing evidence
2025-04-01 – 2025-06-302920000 USD20260730Open filing evidence
2025-01-01 – 2025-06-3012897000 USD20260730Open filing evidence
2025-01-01 – 2025-03-319977000 USD20260430Open filing evidence
2024-01-01 – 2024-12-3135275000 USD20260317Open filing evidence
2024-07-01 – 2024-09-302676000 USD20251030Open filing evidence
2024-01-01 – 2024-09-3031567000 USD20251030Open filing evidence
2024-04-01 – 2024-06-309361000 USD20250808Open filing evidence
2024-01-01 – 2024-06-3028891000 USD20250808Open filing evidence
2024-01-01 – 2024-03-3119530000 USD20250501Open filing evidence
2023-01-01 – 2023-12-3126976000 USD20260317Open filing evidence
2022-01-01 – 2022-12-3114463000 USD20250225Open filing evidence